DBPR-117

N/A

Report date: 2022/10/25 13:06:36

Base Information

Drug NameDBPR-117
Drug Alias NameDBPR-117
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionR-spondin-3 inhibitorsWnt signalling pathway inhibitors
TargetsR-spondin-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesNational Health Research Institutes
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A